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Abstract
The airway epithelium is altered in respiratory disease and is thought to con-
tribute to disease etiology. A caveat to disease research is that the technique of
isolation of bronchial epithelial cells from patients is invasive and cells have a
limited lifespan. The aim of this study was to extensively characterize the plas-
ticity of primary human bronchial epithelial cells that have been engineered to
delay cell senescence including the ability of these cells to differentiate. Cells
were engineered to express BMI-1 or hTERT using viral vector systems. Cells
were characterized at passage (p) early (p5), mid (p10), and late (p15) stage
for: BMI-1, p16, and CK14 protein expression, viability and the ability to dif-
ferentiate at air–liquid interface (ALI), using a range of techniques including
immunohistochemistry (IHC), immunofluorescence (IF), transepithelial elec-
trical resistance (TEER), scanning electron microscopy (SEM), MUC5AC and
beta tubulin (BTUB) staining. BMI-1-expressing cells maintained elevated
levels of the BMI-1 protein and the epithelial marker CK14 and showed a
suppression of p16. BMI-1-expressing cells had a viability advantage, differen-
tiated at ALI, and had a normal karyotype. In contrast, hTERT-expressing
cells had a reduced viability, showed limited differentiation, and had an
abnormal karyotype. We therefore provide extensive characterization of the
plasticity of BMI-1 expressing cells in the context of the ALI model. These
cells retain properties of wild-type cells and may be useful to characterize res-
piratory disease mechanisms in vitro over sustained periods.
Introduction
The airway epithelium acts as the critical interface
between the environment and organ physiology. It acts as
a barrier to potential pathogens and extraneous particles
and helps regulate host defense mechanisms, including
the inflammation process. Under normal conditions, the
bronchial epithelium is composed of ciliated columnar,
mucus-secreting goblet and Clara cells that secrete surfac-
tant. There is accumulating evidence that the airway
epithelium is intrinsically different in airway diseases such
as asthma and chronic obstructive pulmonary disease
(COPD) if compared with the normal type. For example,
bronchial epithelial cells isolated from asthma patients
and cultured in vitro have: (1) defective repair mecha-
nisms (Kicic et al. 2010), (2) altered barrier properties
including reduced tight junction protein expression and
formation (Xiao et al. 2011), (3) elevated expression of
proremodeling factors (Lopez-Guisa et al. 2012), and (4)
when differentiated have increased numbers of goblet and
reduced numbers of ciliated cells (Parker et al. 2010; Gras
et al. 2012). Similarly, genetic studies have identified a
large number of asthma susceptibility genes that are dif-
ferentially expressed in the airway epithelium in asthma
including interleukin 33 (IL33) and thymic stromal lym-
phopoietin (TSLP). This led to the hypothesis that the
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airway epithelium contributes to disease etiology. There-
fore, the airway epithelium represents an attractive thera-
peutic target in asthma. However, more research tools
and cellular assay systems are needed to rapidly move this
area of important research forward.
The most common approach to study bronchial epithe-
lial cells from healthy controls and patients with respira-
tory disease is to isolate cells using bronchoscopic brush
technique (Kelsen et al. 1992) and then culture the cells as
basal cell monolayers or using air–liquid interface (ALI)
differentiation (Stewart et al. 2012a,b). ALI cells form an
epithelial barrier that closely resembles the in vivo architec-
ture of the airway epithelium and is composed of basal,
goblet, and ciliated cells allowing data to be generated in a
more physiological context. However, the bronchoscopic
procedure is invasive with risk to the individual, especially
in people with severe asthma. Moreover, adequate numbers
of cells are hardly collected. Similarly, once isolated and
grown in vitro, the primary airway epithelial cells have a
limited lifespan (i.e., the point at which the cells stop pro-
liferating, typically 4–5 passages). This is often too short to
obtain key experimental data. Importantly, after p4 bron-
chial epithelial cells begin to deviate in their morphology/
phenotype, lose their plasticity required for the differentia-
tion at ALI. These factors make the identification and care-
ful characterization of a method to delay cell senescence
while maintaining the plasticity of the cells highly desir-
able. One approach to delay cell senescence is the suppres-
sion of cyclin-dependent kinase inhibitor, p16(Ink4a), a
tumor suppressor that induces a G1 cell cycle arrest. B-
cell-specific Moloney murine leukemia virus integration
site 1 (BMI-1) is a polycomb protein thought to repress
p16(Ink4a) expression and has previously been shown to
delay cell senescence (Vonlanthen et al. 2001).
In this study, we set out to engineer primary human
bronchial epithelial cells to express different levels of
BMI-1 via alternative promoter constructs and extensively
characterize the cells for effects on viability and plasticity
such as the ability to differentiate at ALI. This was
assessed using a range of techniques including immuno-
histochemistry (IHC), immunofluorescence (IF), transep-
ithelial electrical resistance (TEER), and scanning electron
microscopy (SEM). Importantly, we also investigated gen-
ome stability/integrity through effects on karyotype. Both
wild-type early passage cells and cells engineered to
express hTERT (as a commonly used immortalization
technique) were included in these analyses. We demon-
strate the BMI-1-engineered cells assessed at early (p5),
mid (p10), and late (p15) passage produce elevated
levels of BMI-1 expression with associated suppression of
p16. These cells retain both viability and differentiation
potential of wild-type cells while importantly not demon-
strating the changes in cell karyotype. These features were
apparent across all donor cell populations engineered to
express the elevated levels of BMI-1. These data are in
contrast to hTERT cells that were no longer viable and
did not differentiate at mid passage and demonstrated
gross chromosomal abnormalities. Therefore, BMI-1-engi-
neered bronchial epithelial cells delayed cell senescence
and retained their plasticity including the ability to differ-
entiate at ALI in a comparative manner to low passage
unmodified cells.
Materials and Methods
BMI-1 plasmid construction
Human BMI-1 full-length cDNA was originally obtained
from GeneserviceTM Mammalian Gene Collection (MGC)
Clone, amplified and cloned into pLVX-Puro (Clontech)
using XhoI/BamHI restriction sites and into pFLRu-FH
using MluI/BamHI restriction sites, using standard molec-
ular biology techniques. The retroviral vector pWZL-
BLAST-FLAG-HA-hTERT and corresponding empty
vector backbone were purchased from Addgene (Maida
et al. 2009). All vectors were sequence verified.
Packaging of lentivirus and retrovirus
HEK293T cells were seeded at 2 9 106 cells per 10-cm
diameter dish and were cultured in DMEM, 10% FCS, 1%
penicillin/streptomycin overnight. For lentiviral produc-
tion, the cells were transfected with a mix containing an
8:1 ratio of packaging: envelope vectors, that is, 4.4 lg of
pCMV delta R8.9, 0.6 lg of pCMV-VSV-G (McKay et al.
2011), and 5 lg of the appropriate lentiviral vector (empty
or BMI-1 insert) with 36 lL of TransIT-LT1 (Geneflow).
For retroviral production, the cells were transfected with
5 lg of pKAT (Addgene) and 5 lg of retroviral vector
(empty or with hTERT insert) and 36 lL of TransIT-LT1
(Geneflow). Cells were grown for 48–72 h and the super-
natant containing packaged virus was harvested and ultra-
centrifuged (48,384 g for 3.5 h at 4°C) to produce a
concentrated viral stock which was stored at -80°C.
Primary bronchial epithelial cell culture and
air liquid interface
Normal Human Bronchial Epithelial Cells (NHBEC) were
purchased from Lonza, (Wokingham, UK). Donor 1 cells
were isolated from a 43-year-old Caucasian male with no
history of smoking; Donor 2 cells were isolated from a
56-year-old Caucasian male smoker. NHBEC were grown
in a growth factor-supplemented medium (BEGM) (Lon-
za) and differentiated at ALI in bronchial epithelial differ-
entiation medium (BEDM), according to our previously
2016 | Vol. 4 | Iss. 16 | e12847
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published methods (Stewart et al. 2012a,b). BEDM is
composed of 50:50 Dulbecco’s Modified Eagle’s Medium
(DMEM, Sigma-Aldrich, Dorset, UK):BEBM with Lonza
singlequots, excluding triiodo-L-thyronine and retinoic
acid, but including GA-1000 (Gentamicin and Ampho-
tericin-B). BEDM is supplemented with 50 nmol/L reti-
noic acid, added at time of use. All cells were cultured on
6.5-mm polyester Transwell inserts with a pore size of
0.4 lm (Corning Life Sciences, Amsterdam, The Nether-
lands). Cells were plated at 30,000 cells per insert in an
appropriate medium. When confluent (~3 days), cells
were raised to ALI. Medium was replaced and the apical
face washed with media every 48 h. Cells were fixed for
immunostaining, histology sectioning, and scanning elec-
tron microscopy after 28 days at ALI.
Generation of genetically modified NHBEC
Passage 2 NHBEC were plated in a 6-well plate at 5 9 104
cells per well and grown overnight. These were purchased
heterogeneous NHBEC and not clonal cells. The media was
replaced with 800 lL of BEGM with 2 lg/mL of polybrene
(Hexadimethrine bromide H9268 Sigma) and 6.25 lL of
lentivirus or 12.5 lL of retrovirus stock solutions (minimal
concentrations to give >90% transfection determined
empirically). The plates were incubated at 37°C for 6.5 h
with gentle rocking of the plate every 30 min for the first
2 h. The viral mixture was removed and replaced with
BEGM. After 72 h, selection media was added to the wells
with 300 ng/mL puromycin for the lentiviral-infected cells
and 600 ng/mL blasticidin for the retroviral cells. Cells
with antibiotic resistance after 6 days of selection were
considered to have been stably infected with the appropri-
ate virus expressing BMI-1 or hTERT.
Western blotting
A total of 2 9 105 cells were lysed in SDS loading buffer,
heat denatured, and proteins were separated by elec-
trophoresis using 12% SDS resolving gels. The proteins
were transferred to nitrocellulose and probed for BMI-1,
p16, and b actin expression using mouse anti-p16 (Milli-
pore MAB4133; Watford, UK) at 1 in 1000 dilution
(1 lg/mL), mouse anti-BMI-1 (Millipore Clone F6 Cat
No 05-637) primary antibody at 1 in 1000 dilution, and
rabbit polyclonal anti-b actin (Abcam ab8227, lot 712923,
0.65 mg/mL) primary antibody at 1 in 5000 dilution. Sec-
ondary antibodies were used at 1 in 10000 dilutions and
consisted of goat anti-mouse HRP (Jackson Immuno 115-
035-062) and goat polyclonal anti-rabbit HRP (Sigma
A0545). ECL reagent was used to visualize proteins as
directed by the manufacturer (GE Healthcare RPN2209;
GE Healthcare, Amersham, UK).
Immunofluorescence
ALI-cultured cells were fixed in situ on inserts and trans-
ferred to the glass slides for visualization. Cells were fixed
using 4% formaldehyde and blocked/permeabilized with
PBS, 10% goat serum, 1% BSA, and 0.15% Triton-X.
Cells were incubated with appropriate primary antibodies
at 4°C overnight, and FITC labeled secondary for 1 h at
room temperature before mounting in HardSet DAPI
(Vector Labs). These methods were as previously
described (Stewart et al. 2012b) with the addition of
BMI-1 (Millipore Clone F6) and CK14 (Chemicon
MAB3232) antibodies to the panel. Cells were visualized
using the Zeiss spinning disk confocal microscope and
Volocity software (PerkinElmer, Cambridge, UK).
Cell viability
A total of 2.5 9 103 cells were plated in quadruplicate
wells of a 96-well plate in 200 lL BEGM + GA and incu-
bated for 96–120 h before analysis. 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) at
500 lg/mL in BEGM was added to the wells for 4 h
before termination of the experiment. The media was
then replaced with 200 lL isopropanol and incubated for
10 min to lyse the cells. The plate was read at 570 nm
(with a background subtraction of 690 nm) using a Flexs-
tation (Molecular Devices, Wokingham, UK).
Transepithelial electrical resistance
Transepithelial electrical resistance (TEER) was measured
in differentiating cells using an EVOM2 epithelial volt-
ohm meter (World precision Instruments UK, Stevenage)
to indicate development of tight junctions as described
previously (Stewart et al. 2012b). Briefly, medium was
aspirated and replaced with 1 mL growth medium in the
basolateral and 0.5 mL growth medium in the apical
compartment. Cultures were equilibrated in the incubator
for 30 min before TEER measurement. Apical medium
was then aspirated to restore ALI. TEER values of insert
and medium alone wells was subtracted from the mea-
sured TEER and Ocm2 was calculated by multiplying by
the insert area. For comparison across cell lines and pas-
sage, we calculated area under curve using TEER data
from days 1–28 using GraphPad Prism 6.02 for Windows
(GraphPad Software, San Diego, CA).
Karyotyping
Cells in active growth phase were treated with demecol-
cine solution (Sigma) at 400 ng/mL for 4 h before har-
vesting, swelling (hypotonic solution [0.056 mol/L KCL]),
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and fixing in methanol/glacial acetic acid. The cells were
fixed further two times before slides were produced and
aged, then banded using trypsin and Giemsa staining
before imaging and analyses (completed by Cytogenetics
Unit, City Hospital, Nottingham, UK).
Histological analyses
Fixed transwells were paraffin embedded, sectioned, and
then stained with hematoxylin and eosin (H & E) or
alcian blue using standard approaches.
Scanning electron microscopy
Transwells at day 28 ALI were washed with BEGM media
to remove any mucous and then fixed with 3% glutaralde-
hyde in 0.1 mol/L sodium cacodylate buffer for a mini-
mum of 24 h. The wells were washed three times with
0.1 mol/L phosphate/cacodylate buffer and post fixed for
1 h at room temperature with 1% aqueous osmium tetrox-
ide. The samples were washed with distilled water and then
dehydrated using a graded series of ethanol washes (50, 70,
90, and 100%, respectively). Samples remained submerged
in 100% ethanol, processed when they were dried, and
coated with gold particles. The samples were then imaged
at low and high magnification using a scanning electron
microscope (model JSM-35; JOEL).
Telomerase activity assay
TRAPeze XL Telomerase detection kit was used as directed
by the manufacturer to determine hTERT activity (Milli-
pore S7707). A total of 1 9 105 cells were suspended in
200 lL of CHAPS lysis buffer and incubated on ice for
30 min. The positive cells (1 9 106, provided by the kit)
were treated in the same way. The samples were then cen-
trifuged at 120,000g for 20 min at 4°C. PCR tubes contain-
ing 10 lL 5X TRAPeze XL reaction mix, 0.4 lL Taq
polymerase (5units/lL), 37.6 lL dH2O, and 2 lL of cell
extract, positive template or buffer for the control samples
were run at 30°C for 30 mins followed by 36 cycles of 94°C
for 30 sec, 59°C for 30 sec, and 72°C for 1 min. This was
followed by 72°C for 3 min, 55°C for 25 min, and 4°C
hold. The samples were then diluted in 150 lL of buffer
(10 mmol/L Tris-HCl pH 7.4, 0.15 mol/L NaCl, 2 mmol/L
MgCl2) and fluorescent signals were read at excitation
485 nm and emission 535 nm and excitation 585 nm and
emission 620 nm on the Flexstation (Molecular Devices).
Statistical analyses
GraphPad Prism 6.02 for Windows was used for statistical
analyses. Quantitative data were analyzed using Student’s
t test or ANOVA with Dunnett’s multiple comparison
test. A P <0.05 was considered significant.
Results
Cell generation
We specifically chose two lentiviral vectors with differing
promoters: Cytomegalovirus (CMV) in pLVX-Puro or
human ubiquitin C (UbiC)) in pFLRu-FH to express
BMI-1 in human bronchial epithelial cells with the
hypothesis that the CMV promoter may lead to greater
BMI-1 overexpression than the UbiC promoter (Qin et al.
2010). Lentiviruses were used to transduce passage 2
NHBECs from two donors. This protocol therefore gener-
ated four independent cell populations expressing recom-
binant BMI-1 to evaluate the effect of BMI-1 on cell
plasticity. The transduction efficiency was >95%, as indi-
cated by limited cell death following antibiotic selection
and the pWZL-based constructs gave similar findings
(data not shown). Cell populations generated were fol-
lowed up for ~12 months with focused analyses presented
for (1) Early passage (infection passage 3/actual passage
6), (2) Mid passage (infection passage 5–7/actual passage
8–10), and (3) Late passage (infection passage 8–12/actual
passage 11–15). Finally, a subset of analyses was com-
pleted using extended passage cells (infection passage 17/
actual passage 20). It is important to note that we arbi-
trarily designated these early, mid, and late passage defini-
tions based on passage 20 being the maximum achieved.
NHBECs transduced with lentivirus containing plasmid
vector that did not contain the BMI-1 expression cassette,
that is, empty vectors, stopped growing at mid passage.
Similarly, for the cells containing the pWZL constructs
including hTERT insert cells were not viable at mid pas-
sage, although there were donor differences in these cell
senescence times.
NHBEC-BMI-1 cell populations maintain
elevated levels of BMI-1 expression and
feature p16 suppression during prolonged
culture
Both the pFLRu-BMI-1(UbiC promoter) and pLVX-BMI-
1 (CMV promoter)-engineered cells demonstrated ele-
vated BMI-1 expression as evidenced by Western blotting
in comparison with control vectors without insert at early
passage (Fig. 1A). Importantly, the elevated level of BMI-
1 observed in these cell populations was accompanied by
a decrease in the level of CDK inhibitor p16 (Fig. 1B).
Similarly, BMI-1 immunofluorescence for wild-type cells
(control) at passage 3 showed weak BMI-1 protein
expression in comparison with high nuclear BMI-1
2016 | Vol. 4 | Iss. 16 | e12847
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expression in engineered late passage cells for both donors
demonstrating robust elevated BMI-1 through to late pas-
sage (Fig. 1C). Early and mid passage cells showed similar
elevated BMI-1 expression as determined by immunofluo-
rescence (data not shown). In order to confirm that
genetic modification of cells to overexpress hTERT trans-
lated to increased hTERT enzymatic activity, we deter-
mined telomerase activity in wild-type cells, cells
transfected with empty vector, and those cells engineered
to express hTERT. hTERT activity was elevated in the
hTERT-expressing cell populations in both donors across
early-mid-late passages as anticipated (Fig. 1D).
NHBEC-BMI-1 cell populations have
extended viability
In order to investigate the effect of the genetic modifica-
tions on cell viability, we used the MTT assay as
described (Portelli et al. 2014). Early passage cells con-
taining either BMI-1 vector or pWZL-hTERT showed
increased viability in both donors over 96 or 120 h
(Fig. 2A, B and C, P < 0.05). Similarly, mid passage cells
showed alterations in viability compared to wild-type cells
over 96 h (empty vector controls were no longer viable at
this stage). For donor 1, both BMI-1 cell populations
increased viability compared to wild-type cells (ANOVA,
post hoc P < 0.05), whereas hTERT-engineered cells did
not show altered viability compared to wild-type control.
For donor 2, pFLRu-BMI-1 significantly increased cell
viability and hTERT reduced viability when compared
to wild-type control (ANOVA, post hoc P < 0.05)
with pLVX-BMI-1 cell viability showing no difference
(Fig. 2D). In a similar analysis of late passage cells
(assayed over 120 h), both donors showed pLVX-BMI-1
significantly increased viability, whereas hTERT cells had
a decreased viability (Fig. 2E, ANOVA, post hoc
P < 0.05). Late passage pFLRu-BMI-1 cells showed no
differences in viability compared to wild-type control
cells. These data suggest that late passage NHBECs trans-
duced with the pLVX-BMI-1 lentivirus are the only cell
populations to maintain high viability.
NHBEC-BMI-1 cell populations maintain
epithelial cell marker expression over
prolonged lifespan
In order to begin to characterize the cell phenotype in the
genetically modified cells, we examined the expression of
the epithelial lineage marker, cytokeratin (CK) 14. For
both donors, a very similar level and distribution of
CK14 was observed in wild-type cells at passage 3 and late
passage cells for both BMI-1 vectors using immunofluo-
rescence (Fig. 3). Similarly, donor 1 hTERT-expressing
cells showed comparable expression, however, for donor 2
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Figure 1. BMI-1 epithelial cell populations express elevated levels of BMI-1 protein and show suppression of p16 protein levels. (A) Early
passage-engineered cells express elevated levels of BMI-1 compared to empty vector control cell population as determined by Western blot and
(B) have suppressed levels of p16, (C) BMI-1 immunofluorescence analyses for wild-type cells donor cells (control) show moderate BMI1 levels,
whereas BMI-1-engineered late passage cells show elevated levels in both vector-based approaches, Donor 1 (i–iii) and Donor 2 (iv–vi)). (D)
hTERT activity is elevated in pWZL-hTERT cell population in both donors compared to wild-type cells (control) and control vector cells (individual
experiment for each donor). Donor 1 (fill) and donor 2 (no fill). Positive control is provided by the assay kit. *Note late passage data not
available for pWZL-hTERT donor 2 as this cell population stopped growing.
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pWZL-hTERT, the cells did not reach late passage and
infection passage 8 (passage 10) was the maximum
achieved with limited CK14 expression observed.
ALI differentiated NHBEC-BMI-1 cell
populations show comparative morphology
to nonmodified wild-type cells
To compare the morphology of genetically modified cells
to low passage (p3) wild-type cells grown at air–liquid
interface, we examined sections stained with H & E and
alcian blue to detect mucins. Wild-type NHBECs gener-
ated a pseudostratifed epithelial layer upon ALI showing
similarities to that observed in situ including mucin stain-
ing at the apical side and the presence of cilia (Fig. 4).
Significantly, early, mid, and late passage BMI-1-expres-
sing cells from both lenti-vector constructs maintained
the ability to differentiate and showed the classical
pseudostratified epithelial layer in this model, however,
late passage BMI-1 cells had more diffuse mucin staining
(Fig. 4). In contrast, hTERT-expressing cells failed to
show a differentiated phenotype even at early passage and
in mid and late passage, it was not possible to generate
sections as the cells did not grow and adhere to the tran-
swell.
NHBEC-BMI-1 cell populations retain the
ability to differentiate into multiple cell
types at air liquid interface
In order to further characterize the differentiated pheno-
type of wild-type and genetically modified cells, we used
immunofluorescence for MUC5AC which is a marker of
goblet cells and beta tubulin, which is a marker of ciliated
cells. These data show that early, mid, and late passage
BMI-1-expressing cells maintain differentiation potential
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Figure 2. BMI-1 epithelial cell populations have an extended lifespan with viability increased compared to wild-type bronchial epithelial cells.
Viability (MTT assay) was determined for early passage cells at (A) pFLRu/96 h, (B) pLVX/96 h, and (C) pWZL/120 h demonstrating that the
insertion of BMI1 or hTERT leads to increased viability in Donor 1 (solid bars) and Donor 2 (open bars), *P < 0.05, **P < 0.005, ***P < 0.0005,
****P < 0.00005. (D) Mid passage-engineered cells show alterations in viability compared to wild-type cells assayed for 96 h. (E) Late passage
viability (assayed for 120 h). *note donor 2 hTERT cell population is mid passage (maximum passage achieved).
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and generate a differentiated layer composed of multiple
cell types comparable to wild-type control cells from the
same experiments (Fig. 5). As anticipated in the z-stack
images, both the beta tubulin and MUC5AC staining is
particularly apical. hTERT-expressing cells maintain these
features until cell senescence for this donor.
Control pFLRu-BMI-1 pLVX-BMI-1 pWZL-hTERT Isotype
(i) (ii) (iii) (iv)
(vi) (vii) (viii) (ix)
(v)
(x)
Figure 3. BMI-1 epithelial cell populations retain epithelial cell marker expression over extended passage. Immunofluorescence for cytokeratin
14 confirmed epithelial lineage in wild-type cells (Control) and for late passage engineered cells for Donor 1 (i–iv) and Donor 2 (vi–ix). Note
pWZL-hTERT in donor 2, mid passage was the maximum passage achieved.
Wild-type (p3) pFLRu-BMI-1 pLVX-BMI-1 pWZL-hTERT
La
te
M
id
Ea
rly
Figure 4. BMI-1 epithelial cell populations retain the ability to differentiate at air–liquid interface and show comparative cell composition and
morphology to wild-type cells. Sections of air–liquid interface cultures stained with hematoxylin and eosin or alcian blue stains. Early, mid, and
late passage BMI-1-expressing cells maintain morphology demonstrating a pseudostratified layer with evidence of differentiation into mucus-
producing cells similar to matched wild-type cells (passage 3). Wild-type cells were included in each of the early, mid, and late time point
experiments, hence, three panels. hTERT cell populations were not available for all passages as these did not form differentiated layers and the
cells clumps did not adhere to transwells, hence, after fixing these cells became detached. Data shown for Donor 2, Donor 1 showed similar
results.
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NHBEC-BMI-1 cell populations retain the
ability to differentiate and form an
epithelial barrier
One of the hallmarks of the ALI model is the develop-
ment of tight junctions between the epithelial cells form-
ing a barrier. A surrogate measure of this is the
development of TEER. Therefore, we examined this out-
come in both wild-type and genetically modified cells.
Both donors demonstrated the capacity to develop TEER
as shown by the wild-type cells (passage 3) time course
data (Fig. 6A and B). In Figure 6A, a decrease in TEER
was observed between days 14–21 which we have
observed for other primary human cell donors. Similar
plots were generated for early, mid, and late passage-
engineered cells and to facilitate multiple comparisons
area under the curve values were generated. At early
passage donor 1 cells, all developed a TEER except for
the pWZL empty vector cell population (Fig. 6C). The
level of TEER was variable with pLVX-BMI-1 showing
the most comparable to wild-type control levels
(Fig. 6C). Donor 2 early passage data demonstrated that
only the BMI-1-containing cells were capable of develop-
ing a TEER and in the case of the pLVX-BMI-1, this
was higher than the wild-type control. All empty vector
controls and the pWZL-hTERT did not develop a mea-
surable TEER at passage 6 (Fig. 6D). At mid passage,
the empty vector controls were no longer viable and
comparison of the engineered cells showed that in both
donors, the BMI-1-expressing cells demonstrated a mea-
surable TEER, albeit lower than wild-type, whereas the
hTERT-engineered cells did not (Fig. 6E and F). At late
passage, again the BMI-1-expressing cells demonstrated a
TEER but at a reduced level compared to wild-type cells
(Fig. 6G and H). Across the passage stages, there was a
gradual loss of TEER development in the BMI-1 cell
lines when compared to the wild-type cells (100%) at
each stage, for example, Donor 1 pFLRu-BMI-1: 56.5%,
28.1%, and 29.1% (of wild-type control, 100%) across
early, mid, and late passages. Similarly, Donor 1 pLVX-
BMI-1: 89.5%, 43.5%, 42.1% (of wild-type control,
100%) across early, mid, and late passages. Donor 2
data were more heterogeneous but showed a similar
trend. These data demonstrated that the BMI-1-expres-
sing cells maintain plasticity, differentiate at ALI, and
develop TEER. However, due to our low number of
technical replicates, we were not able to provide more
quantitative comparisons of the absolute levels of differ-
entiation, for example, TEER achieved across cell popu-
lations and/or passages with certainty.
Wild-type (p3) pFLRu-BMI-1 pLVX-BMI-1 pWZL-hTERT
La
te
M
id
Ea
rly
Beta tubulin MUC5AC Beta tubulin MUC5AC Beta tubulin MUC5AC Beta tubulin MUC5AC
Figure 5. BMI-1 epithelial cell populations retain the ability to differentiate at air–liquid interface and stain positively for goblet and ciliated cell
markers. Immunofluorescence including z-stacks of markers for goblet cells (MUC5AC) and ciliated cells (beta tubulin IV) generated in early,
mid, and late passage BMI-1 or hTERT-expressing cells with wild-type control cells (p3). Wild-type cells were included in each of the early, mid,
and late time point experiments, hence, three panels. Data from donor 1 and representative of both donors, however, donor 2 hTERT-
expressing cells did not provide robust ALI cultures post early passage. Note some data were available for hTERT mid passage cells (in contrast
to Fig. 4) due to the gentler processing of the samples for IF. ALI, air–liquid interface; IF, immunofluorescence
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Figure 6. BMI-1 epithelial cell populations retain the ability to differentiate at air–liquid interface and develop transepithelial electrical
resistance. Representative TEER traces for (A) donor 1 and (B) donor 2 wild-type cells at passage 3 demonstrating increasing in TEER during the
ALI differentiation. Area under the curve (AUC) analyses of TEER for early passage-engineered cells for (C) donor 1 and (D) donor 2. Mid
passage TEER (AUC) for (E) donor 1 and (F) donor 2 and late passage TEER (AUC) for (G) donor 1 and (H) donor 2. Empty vector control cells
failed to grow after early passage stage and so are not present on graphs (E–H). Data shows a single experiment for both donors at each
passage. ALI, air–liquid interface; TEER, transepithelial electrical resistance.
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NHBEC-BMI-1 cell populations retain the
ability to differentiate forming ciliated cells
at the apical surface
To further characterize the differentiated epithelial layer
observed in the ALI model, we used scanning electron
microscopy to visualize the apical surface and examine
cilia. These images clearly show cilia projections on the
surface of wild-type cells as we have observed previously
(Fig. 7). For genetically engineered cells, cilia were also
present including the hTERT genetically modified cells
and there was a large degree of heterogeneity. For mid
passage pLVX-BMI-1 cells, there was potentially a
reduced pattern of cilia compared to wild-type control.
Importantly, there was evidence for late passage BMI-1
cells, particularly the pLVX-BMI-1 cells to have ciliated
surfaces (Fig. 7).
NHBEC-BMI-1 cell populations maintain a
stable genome over extended passage
As many approaches to prevent cell senescence have
unwanted effects on the genetic information of the cells,
we completed karyotyping of wild-type and genetically
modified cells at each passage stage to identify gross
changes in chromosomes (>5 megabase rearrangements).
For all BMI-1-expressing cells assayed at early, mid, and
late passage, normal karyotypes were present. In contrast,
an abnormal karyotype was observed for donor 2 hTERT-
expressing cells at mid passage suggesting gross alterations
on chromosomes 6, 13, and 16 and chromosomal frag-
ments that could not be mapped (Fig. 8).
Discussion
In this study, we set out to evaluate methods to delay cell
senescence while maintaining plasticity/differentiation
potential in primary human bronchial epithelial cells. This
is important as these cells have a key role to play in respi-
ratory disease warranting further research. However, such
primary cells are isolated from patients by invasive proce-
dures and have limited lifespan ex vivo. We have devel-
oped two lentiviral systems that enabled us to elevate the
expression of polycomb protein BMI-1 and importantly
suppress p16 levels in cells containing these genetic modi-
fications. Extensive characterization over 12 months
Control cells (p3) pFLRu-BMI-1 pLVX-BMI-1 pWZL-hTERT
La
te
M
id
Ea
rly
Figure 7. BMI-1 epithelial cell populations retain the ability to differentiate at air–liquid interface and demonstrate surface cilia in scanning
electron microscopy. Wild-type control cells at passage 3 show evidence of ciliated cells on the surface of air–liquid interface cultures using
SEM. Wild-type cells were included in each of the early, mid, and late time point experiments, hence, three panels. Both BMI-1- and hTERT
(when viable)-expressing cells grown at ALI show some evidence of ciliated cells on the surface. Data taken from donor 1 and representative of
both donors were analyzed (91700 magnification). ALI, air–liquid interface; SEM, scanning electron microscopy.
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AB
C
Figure 8. Karyotyping identifies abnormalities in the hTERT not BMI-1-engineered cell populations. (A) Representative normal karyotype
showing 22 autosomes and X and Y chromosomes (donor 2 passage 3 cells), (B) Abnormal karyotype including alterations on chromosomes 6,
13, and 16 and chromosomal fragments that could not be mapped observed for donor 2 hTERT mid passage cells and (C) Normal karyotype
for late passage donor 2 pFLRu-BMI-1 cells.
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demonstrated that cells expressing higher levels of BMI-1
have (1) increased viability, (2) an extended number of
cell divisions, (3) maintain basal epithelial morphology,
(4) maintain plasticity, that is, the ability to form a differ-
entiated pseudostratified air–liquid interface model, and
(5) importantly maintain a normal karyotype. These data
suggest that the cell populations generated using BMI-1
induction maintain cell plasticity over extended periods
in the laboratory and may be useful for primary human
bronchial epithelial cell research.
To date, either viral oncogenes have been used to pre-
vent cell senescence in human bronchial epithelial cells
(Willey et al. 1991; Zeitlin et al. 1991; Viallet et al. 1994)
or the introduction of human telomerase reverse tran-
scriptase (hTERT) (Zabner et al. 2003; Piao et al. 2005).
These studies have shown some success, however, a major
limitation is alterations in karyotype (Piao et al. 2005).
Therefore, viral oncogene independent approaches for
prevention of cell senescence have been sought, the most
favored approach being one with an underlying mecha-
nism that decreases the levels of cyclin-dependent kinase
inhibitor, p16(Ink4a), a tumor suppressor that induces a
G1 cell cycle arrest.
BMI-1 is a polycomb transcriptional repressor protein
and is part of the polycomb repressive complex-1 (PRC1)
complex. This complex regulates transcriptional activity at
several loci including the Ink4a locus which encodes the
tumor suppressor proteins p16(Ink4a) and p14(Arf).
BMI-1 has been extensively characterized in the context
of numerous cancers, with both protein and mRNA levels
correlating with disease prognosis (Cao et al. 2011). The
contribution of BMI-1 to multiple cancers is thought to
be due to its role in self-renewal and differentiation of
stem cells (Lessard and Sauvageau 2003). With these
unique properties of regulating cell senescence, BMI-1 has
been the focus of attention particularly in the delay of cell
senescence in many cell types, for example, stem cell fee-
der cells (McKay et al. 2011). Recently, transduction of
HBEC with combinations of hTERT and BMI-1 has gen-
erated some promising data (Fulcher et al. 2009). The
resultant hTERT/BMI-1 cell populations continued to
divide longer than nonmodified cells, and importantly, at
passage 14 and 15 had a diploid karyotype and formed
differentiated pseudostratified morphology following ALI
culture. Interestingly, BMI-1 alone was also introduced to
bronchial epithelial cells in the study of Fulcher and col-
leagues and delayed cell senescence, however, these BMI-1
cell populations were not extensively characterized for
plasticity, a hallmark of low passage basal epithelial cells.
In this study, we set out to significantly extend these
studies and focus away from the use of hTERT to the use
of BMI-1 alone to delay cell senescence in bronchial
epithelial cells and provide more definitive
characterization of the plasticity of cells particularly in the
context of ALI models. To this end, we developed two
new lentiviral systems engineered to express elevated
BMI-1 under the control of CMV or UbiC promoter and
a control retroviral system expressing hTERT for compar-
ison. These systems were used to transduce passage 2 nor-
mal bronchial epithelial cells from two donors. These
genetically engineered cells showed sustained elevation of
BMI-1 as determined by western blot and immunofluo-
rescence and similarly elevated telomerase activity for the
hTERT-engineered cells. As anticipated, the BMI-1-
expressing cells showed consequent suppression of p16 as
observed by several groups (Meng et al. 2010). It is
important to note that BMI-1 is a master regulator of a
very large number of genes and gene families of relevance
to cell senescence, for example, see a recent study using
microarray analyses in BMI-1 knockout mice cells
(Zacharek et al. 2011). In this study, a large number of
genes were differentially expressed (elevated) when BMI-1
was absent which included multiple homeodomain genes
and Cdkn2a (p16/p19) and Cdkn2b (p15). In a more
recent study using BMI-1 / mouse brain tissue in con-
junction with RNA-seq, >500 genes were shown to be up
regulated due to a loss of BMI-1 including identifying a
role for BMI-1 in TGF-b/BMP-ER stress pathways (Gar-
giulo et al. 2013). Therefore, while our p16 suppression
data confirms that our genetic manipulation of BMI-1
has downstream effects on BMI-1 responsive networks, it
is highly likely that multiple pathways underlie the effects
we have observed, for example, p14Arf suppression by
BMI-1 may be highly relevant for apoptosis mechanisms
through the mdm2/TP53 pathway.
In the first set of experiments, we demonstrated that
early passage BMI-1 cells have a slightly higher viability as
did hTERT cells, however, as the passage number
increased hTERT cells lost viability (mid passage and late
passage for the two donors), whereas BMI-1 cells and in
particular those containing the CMV promoter, main-
tained this elevated viability. In order to test the limit of
our system, we also grew the cells further to infection
passage 17/actual passage 20. Only the BMI-1-engineered
cells reached this extended passage as hTERT cells failed
to grow. Importantly, the extended passage BMI-1 cells
had lost their plasticity as assessed by the ability to differ-
entiate at ALI and did not adhere or grow well on the
transwells and had therefore reached the end of their
lifespan (data not shown). These data demonstrating
delay of cell senescence following BMI-1 introduction are
in good agreement with previous work that showed that
cell senescence is delayed to passage 21–24 as we have
shown but not sufficient for immortalization (Fulcher
et al. 2009). These data also identified a potential advan-
tage of the pLVX-CMV lentivirus system. The hTERT
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data is in contrast to a recent study that engineered pri-
mary airway epithelial cells to express hTERT and
reported that these cells grew beyond 40 passages, how-
ever, it is difficult to make conclusions as this study only
used cells from one donor (Walters et al. 2013). Over
extended passage the BMI-1-expressing cells maintained
epithelial marker expression (CK14), whereas this was
more variable with the hTERT-engineered cells. To date,
no other study has evaluated changes in CK14 marker
expression post BMI-1 engineering, however, both BMI-
1/hTERT- and hTERT-engineered cells demonstrated
maintenance of an epithelial phenotype based on addi-
tional markers including KRT5 in hTERT cell populations
(Walters et al. 2013).
An important finding of our current study was that
BMI-1-expressing cells (early-mid-late up to passage 15)
maintain cell plasticity and the ability to differentiate at
air–liquid interface generating a pseudostratified layer com-
posed of basal, goblet, and ciliated cells as observed by sec-
tioning transwells. These data are novel and significantly
extend data on BMI-1/hTERT- or hTERT-engineered cells
that can also maintain this capacity (Fulcher et al. 2009;
Walters et al. 2013). However, the hTERT cell populations
generated in this study did not maintain this plasticity and
showed limited differentiation in contrast to a recent report
(Walters et al. 2013). These data question the utility of
hTERT alone and suggest BMI-1 alone to be the preferred
genetic tool to maintain plasticity in our study. Of note,
several groups are developing combination approaches to
prevent cell senescence in primary epithelial cells using
hTERT, for example, hTERT/BMI-1 can lead to cells that
reach at least 38 population doublings (Fulcher et al. 2009)
and hTERT/cyclin-dependent kinase 4 (Cdk4) epithelial
cells have shown >100 population doublings (Roig et al.
2010). However, in this study, we focused to the use of
BMI-1 alone to reduce transformation of the cells away
from a diploid karyotype and to maintain plasticity.
In agreement with the potential utility of BMI-1 cell
populations, further measures of differentiation in the
context of the air–liquid interface model, mainly goblet
cell (MUC5AC), ciliated cell (beta tubulin) staining,
development of TEER, and SEM showing apical cilia were
all maintained in the late passage BMI-1 cell populations
but not in the hTERT cell populations.
Overall, these data show that for the first time BMI-1-
expressing cells have an extended lifespan, albeit not exten-
sive and suggest that passage 15 cells show very similar
plasticity properties to wild-type cells for these key out-
comes. Of critical importance, compared to other methods
that incorporate the use of hTERT, we did not observe any
alterations in karyotype in BMI-1-expressing cells, whereas
the hTERT cells (p8) had chromosomal abnormalities.
These findings are in complete agreement to the recent
study of hTERT-engineered bronchial epithelial cell popu-
lations which identified chromosomal abnormalities as
early as passage 9 (Walters et al. 2013). Interestingly, anal-
yses of passage 14/15 BMI-1/hTERT failed to identify chro-
mosomal abnormalities suggesting that BMI-1 may be
protective in this context (Fulcher et al. 2009).
This study has several strengths over previous reports
such as including the evaluation of multiple BMI-1 and
hTERT vectors in parallel in multiple primary human
donors. Similarly, the extensive characterization of these
cells for cell plasticity in the context of the ALI model
and for karyotype is novel. These data from four geneti-
cally modified cell populations show comparable effects
of BMI-1 elevation. However, we acknowledge that
greater numbers of donors and technical replicates are
required to provide more quantitative characterization of
cell differentiation, for example, TEER. This represents a
limitation of this study. We have previously identified a
large degree of heterogeneity in both intra- and inter-
donor variation in the air–liquid interface model (Stewart
et al. 2012b), even in the absence of genetic modification
suggesting a substantial study is required involving large
numbers of donors over many years to further define
quantitative changes in cell plasticity using this model.
In conclusion, we provide an in-depth characterization
of the plasticity of human bronchial epithelial cells that
have been engineered to express BMI-1. These cells retain
the plasticity observed in wild-type low passage cells
including the ability to differentiate at ALI that can be
used to model the lining of the airways. These findings
suggest these cells may show utility in many aspects of
respiratory research including in defining airway epithelial
abnormalities in diseases such as asthma, which has the
potential to lead to therapeutic opportunities.
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